GlassScriptPhysician profile
Elizabeth D Lanoue
NPI 1467416123
$7,733.95
in general payments reported to CMS, 2019-2025
55 companies · $1,379 in 2025
The $1,379 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $640 · 2021: $951 · 2022: $1,216 · 2023: $1,547 · 2024: $1,054 · 2025: $1,379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,886 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,885.75 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,637.26 | 2021-2025 | |
| Novo Nordisk INC | $756.92 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $593.11 | 2019-2025 | |
| Amgen INC. | $503.89 | 2019-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $446.45 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Eisai INC. | $330.00 | 2020-2025 | |
| Glaxosmithkline, LLC. | $316.11 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $298.37 | 2021-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $291.43 | 2019-2025 | Farxiga, Airsupra |
| Biohaven Pharmaceutical Holding Company LTD. | $196.61 | 2022 | |
| Astellas Pharma US INC | $185.31 | 2023-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $173.07 | 2022-2024 | Rexulti, Abilify Maintena |
| Currax Pharmaceuticals LLC | $154.23 | 2019-2021 | |
| Amarin Pharma, INC. | $136.01 | 2020-2021 | |
| Exact Sciences Corporation | $131.55 | 2023-2025 | Cologuard Collection Kit |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Lanoue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.